Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study.
Dongjuan XuHuan ZhouTingxia ZhangWeiwei GongJieming ZhongHan YuFujian ChenWansi ZhongShenqiang YanMin Lounull nullPublished in: Journal of the American Heart Association (2024)
The use of antiplatelet therapy lessened as platelet count decreased in patients with AIS with thrombocytopenia. However, our findings suggest that antiplatelet medications remain safe and effective for this population.